1.
A cannabidiol aminoquinone derivative activates the PP2A/B55α/HIF pathway and shows protective effects in a murine model of traumatic brain injury. Navarrete C, García-Martín A, Correa-Sáez A, Prados ME, Fernández F, Pineda R, Mazzone M, Álvarez-Benito M, Calzado MA, Muñoz E.
J Neuroinflammation. 2022 Jul 9;19(1):177. doi: 10.1186/s12974-022-02540-9.
PMID: 35810304
2.
Recent insights into astrocytes as therapeutic targets for demyelinating diseases. Gorter RP, Baron W.
Curr Opin Pharmacol. 2022 Jul 6;65:102261. doi: 10.1016/j.coph.2022.102261. Online ahead of print.
PMID: 35809402 Review.
3.
Lifestyle factors in multiple sclerosis disability progression and silent brain damage: A cross-sectional study. Van Hijfte L, Loret G, Bachmann H, Reynders T, Breuls M, Deschepper E, Kuhle J, Willekens B, Laureys G.
Mult Scler Relat Disord. 2022 Jul 3;65:104016. doi: 10.1016/j.msard.2022.104016. Online ahead of print.
PMID: 35809391
4.
Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis. Titus HE, Xu H, Robinson AP, Patel PA, Chen Y, Fantini D, Eaton V, Karl M, Garrison ED, Rose IVL, Chiang MY, Podojil JR, Balabanov R, Liddelow SA, Miller RH, Popko B, Miller SD.
Glia. 2022 Jul 9. doi: 10.1002/glia.24231. Online ahead of print.
PMID: 35809238
5.
Progress in Mechanism of Astragalus membranaceus and Its Chemical Constituents on Multiple Sclerosis. Peng Y, Deng X, Yang SS, Nie W, Tang YD.
Chin J Integr Med. 2022 Jul 9. doi: 10.1007/s11655-022-3535-6. Online ahead of print.
PMID: 35809178 Review.
6.
Posterior segment spectral domain oct in the differential diagnosis of bilateral temporal optic neuropathy and its correlation with visual acuity. Buelens T, Fils JF, Willermain F.
Int Ophthalmol. 2022 Jul 9. doi: 10.1007/s10792-022-02408-0. Online ahead of print.
PMID: 35809163
7.
Clinical significance of serum ferritin in patients with systemic sclerosis. Jiang Y, Li X, Zhou W, Jin M, Li S, Lao Y, Zhu H, Wang J.
J Clin Lab Anal. 2022 Jul 9:e24597. doi: 10.1002/jcla.24597. Online ahead of print.
PMID: 35808930
8.
B cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients. Asplund Högelin K, Ruffin N, Pin E, Hober S, Nilsson P, Starvaggi Cucuzza C, Khademi M, Olsson T, Piehl F, Al Nimer F.
Eur J Neurol. 2022 Jul 8. doi: 10.1111/ene.15492. Online ahead of print.
PMID: 35808856
9.
Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health. Maiuolo J, Musolino V, Gliozzi M, Carresi C, Scarano F, Nucera S, Scicchitano M, Oppedisano F, Bosco F, Macri R, Palma E, Muscoli C, Mollace V.
Nutrients. 2022 Jun 29;14(13):2711. doi: 10.3390/nu14132711.
PMID: 35807891 Review.
10.
Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis. Ortíz GG, Briones-Torres AL, Benitez-King G, González-Ortíz LJ, Palacios-Magaña CV, Pacheco-Moisés FP.
Molecules. 2022 Jun 30;27(13):4217. doi: 10.3390/molecules27134217.
PMID: 35807462
11.
Correlation of Nabiximols Dose to Steady-State Concentrations of Cannabinoids in Urine Samples from Patients with Multiple Sclerosis. Birke R, Meister S, Winkelmann A, Hinz B, Walther UI.
J Clin Med. 2022 Jun 27;11(13):3717. doi: 10.3390/jcm11133717.
PMID: 35807001
12.
Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review. Sirbu CA, Ivan R, Vasile TM, Eftimie LG, Costache DO.
J Clin Med. 2022 Jun 27;11(13):3702. doi: 10.3390/jcm11133702.
PMID: 35806991
13.
Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Cohort Study. Hernández-Preciado MR, Marquez-Pedroza J, Sánchez-Rosales NA, García-Rivera JJ, Kobayashi-Gutiérrez A, Torres-Mendoza BM, Chavarría-Avila E, Montaño-Serrano RA, Cortes-Enriquez F, Mireles-Ramírez MA.
J Clin Med. 2022 Jun 22;11(13):3584. doi: 10.3390/jcm11133584.
PMID: 35806869
14.
GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. De Masi R, Orlando S.
Int J Mol Sci. 2022 Jul 1;23(13):7373. doi: 10.3390/ijms23137373.
PMID: 35806376 Review.
15.
Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome. González-Madrid E, Rangel-Ramírez MA, Mendoza-León MJ, Álvarez-Mardones O, González PA, Kalergis AM, Opazo MC, Riedel CA.
Int J Mol Sci. 2022 Jun 25;23(13):7080. doi: 10.3390/ijms23137080.
PMID: 35806081 Review.
16.
Human IL12p80 Promotes Murine Oligodendrocyte Differentiation to Repair Nerve Injury. Chung YF, Chen JH, Li CW, Hsu HY, Chen YP, Wang CC, Chiu IM.
Int J Mol Sci. 2022 Jun 23;23(13):7002. doi: 10.3390/ijms23137002.
PMID: 35806005
17.
Cytokine Profile in Patients with Multiple Sclerosis Following Exercise: A Systematic Review of Randomized Clinical Trials. Najafi P, Hadizadeh M, Cheong JPG, Mohafez H, Abdullah S.
Int J Environ Res Public Health. 2022 Jul 2;19(13):8151. doi: 10.3390/ijerph19138151.
PMID: 35805808 Review.
18.
Nociplastic Pain in Multiple Sclerosis Spasticity: Dermatomal Evaluation, Treatment with Intradermal Saline Injection and Outcomes Assessed by 3D Gait Analysis: Review and a Case Report. De Blasiis P, de Sena G, Signoriello E, Sirico F, Imamura M, Lus G.
Int J Environ Res Public Health. 2022 Jun 27;19(13):7872. doi: 10.3390/ijerph19137872.
PMID: 35805532
19.
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives. Bravo GÁ, Cedeño RR, Casadevall MP, Ramió-Torrentà L.
Cells. 2022 Jun 29;11(13):2058. doi: 10.3390/cells11132058.
PMID: 35805142 Review.
1.
In vivo Quantitative Imaging of Hippocampal Inflammation in Autoimmune Neuroinflammatory Conditions: A Systematic Review. Nwaubani P, Cercignani M, Colasanti A.
Clin Exp Immunol. 2022 Jul 8:uxac058. doi: 10.1093/cei/uxac058. Online ahead of print.
PMID: 35802780
2.
Rebound syndrome in two cases of MS patients after teriflunomide cessation. Labauge P, Ayrignac X, Prin P, Charif M, Carra-Dalliere C.
Acta Neurol Belg. 2022 Jul 8. doi: 10.1007/s13760-022-01929-w. Online ahead of print.
PMID: 35802339 No abstract available.
3.
Quantitative Meta-analyses of Cognitive Abilities in Children With Pediatric-onset Multiple Sclerosis. Lysenko ES, Bogdanova MD, Arsalidou M.
Neuropsychol Rev. 2022 Jul 8. doi: 10.1007/s11065-022-09546-3. Online ahead of print.
PMID: 35802297 Review.
4.
Quality of Life in Multiple Sclerosis Patients: Influence of Gender, Age and Marital Status. Sabanagic-Hajric S, Suljic E, Memic-Serdarevic A, Sulejmanpasic G, Mahmutbegovic N.
Mater Sociomed. 2022 Mar;34(1):19-24. doi: 10.5455/msm.2022.33.19-24.
PMID: 35801069 Free PMC article.
5.
Positive effects of Phycocyanobilin on gene expression in glutamate-induced excitotoxicity in SH-SY5Y cells and animal models of multiple sclerosis and cerebral ischemia. Gardón DP, Cervantes-Llanos M, Matamoros BP, Rodríguez HC, Tan CY, Marín-Prida J, Falcón-Cama V, Pavón-Fuentes N, Lemus JG, Ruiz LCB, Argudin TD, Donato GM, Perera Y, Yang K, Pentón-Rol G.
Heliyon. 2022 Jun 20;8(6):e09769. doi: 10.1016/j.heliyon.2022.e09769. eCollection 2022 Jun.
PMID: 35800718 Free PMC article.
6.
Editorial: Role of Inflammation in Neurodegenerative Diseases. Koronyo-Hamaoui M, Gaire BP, Frautschy SA, Alvarez JI.
Front Immunol. 2022 Jun 21;13:958487. doi: 10.3389/fimmu.2022.958487. eCollection 2022.
PMID: 35799792 Free PMC article. No abstract available.
7.
Emerging role of neuregulin-1beta1 in pathogenesis and progression of multiple sclerosis. Ziaee SM, Karimi-Abdolrezaee S.
Neural Regen Res. 2023 Jan;18(1):133-134.
PMID: 35799530 No abstract available.
8.
Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes? Espírito-Santo S, Coutinho VG, Alcantara Gomes FC.
Neural Regen Res. 2023 Jan;18(1):127-128. doi: 10.4103/1673-5374.340407.
PMID: 35799527 No abstract available.
9.
Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors. Sharif NA.
Neural Regen Res. 2023 Jan;18(1):5-17. doi: 10.4103/1673-5374.343887.
PMID: 35799502 Review.
10.
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study. Albano V, Dammacco R, Manni A, Sisto D, Iaffaldano A, Mavilio A, Alessio G, Trojano M, Paolicelli D.
Eur J Ophthalmol. 2022 Jul 7:11206721221112803. doi: 10.1177/11206721221112803. Online ahead of print.
PMID: 35799453
11.
The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis. Artola M, Hernando A, Vidal O, Vidal N, Cuenca E, Horno R, Robles MÁ, Oriol C, Peralta S, Solana MAJ, Rubio M, Montero C, Lleixà M, Zabay C, Martin M, Leon I, Molinos C, Matamoros M, Mercadé L, Fornali O, Montero L, Saiz A, Solà-Valls N.
J Clin Nurs. 2022 Jul 7. doi: 10.1111/jocn.16421. Online ahead of print.
PMID: 35799407
2022 July 07
1.
What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us? Krämer J, Wiendl H.
Neurotherapeutics. 2022 Jul 6. doi: 10.1007/s13311-022-01246-3. Online ahead of print.
PMID: 35794296 Review.
2.
Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes. Pietrobon A, Yockell-Lelièvre J, Flood TA, Stanford WL.
Cell Rep. 2022 Jul 5;40(1):111048. doi: 10.1016/j.celrep.2022.111048.
PMID: 35793620
3.
Photobiomodulation at 830 nm Reduced Nitrite Production by Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Subjects. Tolentino M, Cho CC, Lyons JA.
Photobiomodul Photomed Laser Surg. 2022 Jul 6. doi: 10.1089/photob.2021.0170. Online ahead of print.
PMID: 35793511
4.
Sensitivity of portable low-field magnetic resonance imaging for multiple sclerosis lesions. Arnold TC, Tu D, Okar SV, Nair G, By S, Kawatra KD, Robert-Fitzgerald TE, Desiderio LM, Schindler MK, Shinohara RT, Reich DS, Stein JM.
Neuroimage Clin. 2022 Jun 27;35:103101. doi: 10.1016/j.nicl.2022.103101. Online ahead of print.
PMID: 35792417
5.
Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis. Calabrese CM, Kirchner E, Husni EM, Moss BP, Fernandez AP, Jin Y, Calabrese LH.
Arthritis Rheumatol. 2022 Jul 6. doi: 10.1002/art.42287. Online ahead of print.
PMID: 35791921
6.
Telomere length and Multiple Sclerosis: A Mendelian Randomization Study. Ma Y, Wang M, Chen X, Ruan W, Yao J, Lian X.
Int J Neurosci. 2022 Jul 6:1-9. doi: 10.1080/00207454.2022.2098737. Online ahead of print.
PMID: 35791675
7.
Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis. Dupree JL, Paez PM, Tiwari-Woodruff SK, Denton TT, Hensley K, Angeliu CG, Boullerne AI, Kalinin S, Egge S, Cheli VT, Denaroso G, Atkinson KC, Feri M, Feinstein DL.
ASN Neuro. 2022 Jan-Dec;14:17590914221112352. doi: 10.1177/17590914221112352.
PMID: 35791633
8.
Impact of vaccination on COVID-19 outcome in multiple sclerosis. Bsteh G, Gradl C, Heschl B, Hegen H, Di Pauli F, Assar H, Leutmezer F, Traxler G, Krajnc N, Zulehner G, Hiller MS, Rommer P, Wipfler P, Guger M, Enzinger C, Berger T; AUT-MuSC investigators.
Eur J Neurol. 2022 Jul 5. doi: 10.1111/ene.15488. Online ahead of print.
PMID: 35791496
9.
[Fasudil reduces apoptosis of SH-SY5Y cells induced by H2O2 and promotes synaptic plasticity by inhibiting neurite outgrowth inhibitor A and its receptor (NogoA/NgR) signaling pathway]. Guo M, Zhang H, Yu J, Zhang P, Wang Y, Wei W, Song L, Chai Z, Yu J, Ma C.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022 Jul;38(7):625-631.
PMID: 35786457 Chinese.
10.
Alterations in circulating levels of vitamin D binding protein, total and bioavailability of vitamin D in diabetic retinopathy patients. Maghbooli Z, Ebrahimi Meimand S, Malek Hosseini AA, Shirvani A.
BMC Endocr Disord. 2022 Jul 1;22(1):169. doi: 10.1186/s12902-022-01084-6.
PMID: 35778716 Free PMC article.
Nejnovější komentáře